| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$11 |
Options Prospectus
|
29 May 2025 9:59AM |
$0.027 |
$0.015 |
fallen by
44.44%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- The Prospectus offers up to 110,293,931 New Options to eligible shareholders on a 1-for-5 basis.
- The offer price for each New Option is $0.01, exercisable at $0.06 per Option on or before 30 June 2027.
- The Options Offer is non-renounceable and only available to shareholders with a registered address in New Zealand or Australia as of the Record Date.
- Funds raised from the offer will be used for working capital, product development, sales and marketing, and general corporate purposes.
- Directors and related parties may participate in the offer, with appropriate disclosure provided.
- The Prospectus describes potential risks including dilution of shareholding, market risk, business risks, and regulatory risks.
- A detailed timetable for the Options Offer is provided, including key dates for opening, closing, and allotment.
- The company outlines its current business operations in medical devices, specifically its cervical cancer screening technology.
- The Prospectus discloses financial information, company structure, and details of existing Options on issue.
- Investors are encouraged to read the entire document and seek professional advice before making investment decisions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$199 |
Michael Cottier Appendix 3Y
|
29 May 2025 9:59AM |
$0.960 |
$1.010 |
risen by
5.21%
|
|
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$11 |
Corporate Action Notice
|
29 May 2025 9:59AM |
$0.027 |
$0.015 |
fallen by
44.44%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscreen Group Limited (NZX/ASX: TRU) has announced a 1 for 5 pro-rata renounceable rights offer to raise up to NZ$2.3 million.
- The offer price per new share is NZ$0.06, which is a discount to the last closing price of NZ$0.073 on June 14, 2024.
- Eligible shareholders on the record date of June 21, 2024 will be able to participate in the rights offer.
- The offer opens on June 24, 2024 and closes on July 9, 2024.
- Shareholders may apply for additional shares through a shortfall facility if there are any unsubscribed shares after the offer.
- Funds raised will be used for working capital, sales and marketing initiatives, and continued product development.
- Directors and major shareholders have indicated their intent to participate in the offer.
- A cleansing notice and other required documents will be provided in accordance with the Financial Markets Conduct Act 2013.
- The rights offer is not underwritten.
- Shareholders outside New Zealand and Australia may not be eligible to participate, subject to relevant securities laws.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$11 |
SPP Offer Booklet
|
29 May 2025 9:59AM |
$0.027 |
$0.015 |
fallen by
44.44%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscreen Group Limited is offering a Share Purchase Plan (SPP) to eligible shareholders.
- The SPP enables shareholders to buy additional shares without paying brokerage or transaction fees.
- The offer is capped, and applications may be scaled if oversubscribed.
- Funds raised through the SPP will be used to support commercial objectives, market expansion, and development of Truscreen’s products.
- Key offer dates, eligibility requirements, and application instructions are detailed in the document.
- Participation is voluntary and subject to terms and conditions stated in the booklet.
- The company provides a summary of business operations, recent financial performance, and risk factors related to the investment.
- TRU’s cervical cancer screening technology is a focus area for the funds raised.
- Risks include market, technological, and operational uncertainties.
- Shareholders are advised to seek independent financial advice before participating.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$11 |
Updated Investor Presentation
|
29 May 2025 9:59AM |
$0.027 |
$0.015 |
fallen by
44.44%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscreen Group Limited develops and commercializes a unique real-time cervical cancer screening device.
- The device uses opto-electric technology to detect precancerous and cancerous cervical tissue without the need for laboratory infrastructure.
- TruScreen is positioned for markets with limited access to cytology (Pap smear) and HPV testing, targeting low- and middle-income countries.
- Cervical cancer remains a major global health challenge, especially in developing regions, with large unmet screening needs.
- The device is CE marked, TGA listed, and approved in several major markets including China, Mexico, Russia, and Vietnam.
- Recent progress includes commercial launches in China and Vietnam, with increasing adoption in Eastern Europe and other global markets.
- TruScreen has entered distribution and strategic partnership agreements to drive sales and market penetration.
- Clinical studies show TruScreen offers comparable or superior sensitivity to existing screening methods, with advantages in ease of use and immediacy of results.
- The company’s business model includes direct device sales and recurring revenue from single-use sensors.
- Financial updates indicate growing revenues and investments in market expansion, product development, and regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$11 |
Truscreen Announces Opening of a NZ$3 million Capital Raise
|
29 May 2025 9:59AM |
$0.027 |
$0.015 |
fallen by
44.44%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- Truscreen Group Limited announces a NZ$3 million capital raise.
- The capital raise is to fund commercialization and expansion of TruScreen's cervical cancer screening technology.
- The offer includes a private placement and a share purchase plan, targeting both professional and retail investors.
- Proceeds will be used for sales and marketing, regulatory approvals, clinical studies, working capital, and strengthening the financial position.
- Offer structure, pricing, timeline, and eligibility criteria for investors are detailed in the announcement.
- Announcement date is 19 December 2023.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gladiator Resources Limited (GLA) ORDINARY FULLY PAID |
Materials |
- |
Uranium niobium and tantalum at the Eland Project
|
29 May 2025 9:59AM |
$0.009 |
$0.013 |
risen by
44.44%
|
|
| QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$4 |
Reinstatement to Quotation
|
29 May 2025 9:57AM |
$0.054 |
$0.016 |
fallen by
70.37%
|
|
QEM - Price-sensitive ASX Announcement
Full Release
Key Points
- QEM Limited has been reinstated to quotation on the ASX as of 4 June 2024.
- The company was previously under voluntary suspension pending a capital raising and satisfaction of ASX requirements.
- QEM Limited successfully completed a capital raising to support its operations.
- The company provided updates on the Julia Creek Vanadium and Oil Shale Project.
- Significant progress was reported on project studies, site works, and regulatory engagement.
- QEM Limited renewed its focus on advancing feasibility studies and development activities.
- Financial updates confirm the company is now sufficiently funded for its planned activities.
- The ASX lifted QEM's suspension after all listing and quotation conditions were met.
- The announcement details operational, strategic, and financial aspects of QEM's future plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$4 |
Proposed issue of securities - QEM
|
29 May 2025 9:56AM |
$0.054 |
$0.016 |
fallen by
70.37%
|
|
| QEM Limited (QEM) ORDINARY FULLY PAID |
Materials |
$4 |
QEM Appoints New CEO, $2.05M in Strongly Supported Placement
|
29 May 2025 9:56AM |
$0.054 |
$0.016 |
fallen by
70.37%
|
|
QEM - Price-sensitive ASX Announcement
Full Release
Key Points
- QEM Limited appoints Mr. David Fitch as new CEO.
- Successful $2.05 million placement completed.
- Funds raised will support Julia Creek Vanadium and Oil Shale Project.
- Placement was strongly supported by existing and new investors.
- Outgoing CEO Mr. John Foley acknowledged for his service.
- Mr. Fitch brings significant resources industry experience.
- Funds will also be used for corporate and working capital purposes.
- Announcement strengthens QEM Limited’s leadership and financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gold Mountain Limited (GMN) ORDINARY FULLY PAID |
Materials |
$13 |
Application for quotation of securities - GMN
|
29 May 2025 9:56AM |
$0.002 |
$0.073 |
risen by
3,550%
|
|
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$199 |
Kym Evans Appendix 3Y
|
29 May 2025 9:55AM |
$0.960 |
$1.010 |
risen by
5.21%
|
|
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$67 |
Share Options release from escrow
|
29 May 2025 9:54AM |
$0.330 |
$0.465 |
risen by
40.91%
|
|
| Firetail Resources Limited (FTL) ORDINARY FULLY PAID |
Materials |
- |
Trading Halt
|
29 May 2025 9:54AM |
$0.060 |
$0.110 |
risen by
83.33%
|
|
FTL - Price-sensitive ASX Announcement
Full Release
Key Points
- Firetail Resources Limited (ASX: FTL) requested a trading halt on 20 December 2023.
- The halt was pending an announcement concerning a material transaction.
- The trading halt aimed to ensure the market remained fully informed.
- The halt was to last until the announcement or the start of trading on 22 December 2023.
- The company was not aware of any reason the trading halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$5,728 |
SEC Form 4
|
29 May 2025 9:54AM |
$32.680 |
$33.110 |
risen by
1.32%
|
|
| Gold Mountain Limited (GMN) ORDINARY FULLY PAID |
Materials |
$13 |
Notification regarding unquoted securities - GMN
|
29 May 2025 9:53AM |
$0.002 |
$0.073 |
risen by
3,550%
|
|
| Gold Mountain Limited (GMN) ORDINARY FULLY PAID |
Materials |
$13 |
Issue of entitlement offer shortfall shares
|
29 May 2025 9:53AM |
$0.002 |
$0.073 |
risen by
3,550%
|
|
GMN - Price-sensitive ASX Announcement
Full Release
Key Points
- Gold Mountain Limited announced the issue of shortfall shares from an entitlement offer.
- The entitlement offer was part of the company’s capital raising measures.
- Shortfall shares were allocated to applicants who subscribed beyond their entitlement.
- The document details the number of shares allocated and the resulting capital structure.
- Legal and procedural compliance with ASX and regulatory requirements is highlighted.
- Directors and company officers confirmed the completion of the entitlement offer process.
- The announcement ensures transparency in the share allocation and reporting process.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$187 |
Trading Halt
|
29 May 2025 9:52AM |
$0.480 |
$0.810 |
risen by
68.75%
|
|
GHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Golden Horse Minerals Limited (GHM) has requested a trading halt on its securities.
- The trading halt was announced on 14 June 2024.
- The reason for the trading halt is an upcoming announcement relating to a capital raising.
- The trading halt will remain until the earlier of either 18 June 2024 or the release of the relevant announcement.
- The halt is to ensure the market is properly informed prior to trading resumption.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Knosys Limited (KNO) ORDINARY FULLY PAID |
Information Technology |
$5 |
Presentation - Growth Strategy Update Webinar
|
29 May 2025 9:51AM |
$0.031 |
$0.024 |
fallen by
22.58%
|
|
KNO - Price-sensitive ASX Announcement
Full Release
Key Points
- Knosys Limited delivered a strategic update focused on growth and transformation.
- The company operates three SaaS platforms: KIQ Cloud (knowledge management), GreenOrbit (intranet solution), and Libero (library management).
- Recent acquisitions and integration of platforms aim to strengthen cross-selling and upselling opportunities.
- Revenue growth is supported by an increasing proportion of recurring SaaS revenue.
- Customer base expanded across diverse industries and geographies.
- The company is investing in product innovation and digital transformation solutions.
- Operational efficiency improvements and roadmap to profitability were discussed.
- International expansion remains a core strategic priority.
- Emphasis on leveraging demand for digital knowledge management and workflow solutions.
- Management highlighted ongoing commitment to team development and delivering shareholder value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadCloud Limited (RCL) ORDINARY FULLY PAID |
Information Technology |
$15 |
1H FY25 Results Presentation
|
29 May 2025 9:51AM |
$0.110 |
$0.100 |
fallen by
9.09%
|
|
| Vanguard US Total Market Shares Index ETF (VTS) |
Financials |
$6,362 |
US SEC Filing of Form N-PORT
|
29 May 2025 9:50AM |
$451.800 |
$507.380 |
risen by
12.30%
|
|
| DigitalX Limited (DCC) ORDINARY FULLY PAID |
Information Technology |
$63 |
DigitalX Acquires Additional Solana Position
|
29 May 2025 9:48AM |
$0.066 |
$0.042 |
fallen by
36.36%
|
|
| ReadCloud Limited (RCL) ORDINARY FULLY PAID |
Information Technology |
$15 |
Underlying EBITDA growth of 73% in 1H FY25
|
29 May 2025 9:48AM |
$0.110 |
$0.100 |
fallen by
9.09%
|
|
RCL - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying EBITDA grew by 73% in 1H FY25 compared to the previous period.
- Revenue increased significantly, reflecting strong demand in core markets.
- Gross margin improvements contributed to overall profitability.
- Cost control and operational efficiency were major focus areas.
- Expansion of digital offerings and partnerships supported growth.
- Strategic execution drove positive momentum in the education sector.
- ReadCloud aims to further scale its operations and enhance shareholder value.
- Commitment to innovation and quality in educational resources.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ReadCloud Limited (RCL) ORDINARY FULLY PAID |
Information Technology |
$15 |
Appendix 4D and Half Year Financial Report
|
29 May 2025 9:47AM |
$0.110 |
$0.100 |
fallen by
9.09%
|
|
RCL - Price-sensitive ASX Announcement
Full Release
Key Points
- ReadCloud Limited (RCL) released its Appendix 4D and Half Year Financial Report for the six months ended 31 December 2023.
- Revenue declined compared to the previous period, largely due to a decrease in student numbers in the VET segment.
- The core Schools business maintained stable revenue and continued growth in digital curriculum delivery.
- Operating expenses were impacted by strategic restructuring and investments in technology.
- Net loss after tax increased compared to the previous period, influenced by lower VET revenues and cost base adjustments.
- The company implemented cost-saving measures and targeted efficiencies in response to market conditions.
- RCL remains focused on expanding its digital curriculum solutions and exploring new growth opportunities within education.
- The financial results are based on accounts that have been reviewed but not audited.
- The report details segment performance, cash flows, risks, and going concern considerations.
- Board commentary notes the company’s commitment to achieving sustainable, profitable growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elders Limited (ELD) ORDINARY FULLY PAID |
Consumer Staple |
$1,494 |
ACCC releases Statement of Issues
|
29 May 2025 9:47AM |
$6.200 |
$6.995 |
risen by
12.82%
|
|
ELD - Price-sensitive ASX Announcement
Full Release
Key Points
- ACCC released a Statement of Issues about Elders Limited's proposed acquisition of AIRR.
- Preliminary competition concerns relate to the supply of rural merchandise and agricultural chemicals.
- Potential for a substantial lessening of competition in regional and local markets identified.
- The ACCC is seeking submissions from interested parties regarding the transaction’s impact.
- The review process includes further investigation and a final decision will be made after considering submissions.
- ACCC outlines market structures, potential overlaps, and possible impacts on prices and service quality.
- The Statement of Issues is part of ACCC’s standard process for assessing complex or potentially anti-competitive mergers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
